f Salmonella enterica serovar Typhi, the causative agent of typhoid fever, is highly clonal and genetically conserved, making isolate subtyping difficult. We describe a standardized multiplex ligation-dependent probe amplification (MLPA) genotyping scheme targeting 11 key phylogenetic markers of the S. Typhi genome. The MLPA method demonstrated 90% concordance with single nucleotide polymorphism (SNP) typing, the gold standard for S. Typhi genotyping, and had the ability to identify isolates of the H58 haplotype, which is associated with resistance to multiple antimicrobials. Additionally, the assay permitted the detection of fluoroquinolone resistance-associated mutations in the DNA gyrase-encoding gene gyrA and the topoisomerase gene parC with a sensitivity of 100%. The MLPA methodology is simple and reliable, providing phylogenetically and phenotypically relevant genotyping information. This MLPA scheme offers a more-sensitive and interpretable alternative to the nonphylogenetic subgrouping methodologies that are currently used in reference and research laboratories in areas where typhoid is endemic.
T yphoid fever, caused by Salmonella enterica serovar Typhi (S. Typhi), remains a significant cause of mortality and morbidity in many regions of the world (1, 2) . S. Typhi is a pathogen that is exclusive to humans, and this exquisite level of host restriction is reflected in the genome and population structure of the organism (3) . S. Typhi isolates share an exceptionally high level of genetic conservation, making informative subtyping for local and international epidemiology challenging (3) . Many methods involving both phenotypic and genotypic techniques have been developed to differentiate between S. Typhi isolates. Phage typing was long considered the standard method for strain subtyping; however, this technique provides little or no phylogenetic information, is technically intensive, and is only performed in specialized reference laboratories (4, 5) . Multilocus sequence typing (MLST) cannot productively be applied to S. Typhi because of its monophyletic nature (6) . Other molecular techniques, including random amplified polymorphic DNA PCR (RAPD-PCR), pulsed-field gel electrophoresis (PFGE), and amplified fragment length polymorphisms (AFLP), have some discriminatory power but provide a limited ability to define absolute phylogenetic and epidemiological relationships between isolates (7-9). More recently, genome sequencing and the identification of single nucleotide polymorphisms (SNPs) have provided the first well-defined phylogenetic framework within which to assign S. Typhi isolates to irrefutable genotypes that can describe the population (10) (11) (12) (13) . These studies revealed that S. Typhi genotypes are globally dispersed but are increasingly dominated by a single genotype (H58), which commonly displays resistance to multiple antimicrobials. H58 isolates frequently harbor multidrug-resistant incompatibility group HI1 (IncHI1) plasmids, as well as mutations in the gyrA gene, which confer reduced susceptibility to fluoroquinolones (7, 13) .
While SNP detection and genome sequencing are the gold standards for S. Typhi subtyping (7, 10, 11) , these methodologies remain in the domain of research institutions, which have the facilities, expertise, and infrastructure to support these activities. Therefore, there is a translation gap that stands in the way of utilizing genomic information for subtyping S. Typhi in endemic locations. To address this, we have developed a simple transportable method for genotyping S. Typhi that can be performed in a laboratory with only modest molecular biology capabilities.
S. Typhi genomes harbor several genomic insertions and deletions (indels) that we hypothesize to be phylogenetically informative and may be used as markers for inferring genotypes within the S. Typhi population (12) . Therefore, we predicted that by assaying for selected indels in the S. Typhi genome, we can infer genotype, rather than having to perform genome-wide SNP analysis or genome sequencing. Multiplex ligation-dependent probe amplification (MLPA) is a PCR method that permits multiple DNA sequence targets to be amplified with a single primer pair (14) . The ability of the method to detect DNA signatures, as well as individual SNPs, increases its potential utility and provides a system that can be globally standardized. We have designed, validated, and used an MLPA assay to genotype S. Typhi isolates and investigate the molecular epidemiology of typhoid in Asia. Our data show that S. Typhi MLPA is simple, robust, and comparable to the gold standard of SNP typing, permitting the identification of the major genotypes, as well as mutations that are associated with reduced susceptibility to fluoroquinolones. The method presented here can be applied to other organisms and represents an alternative to MLST, PFGE, genome sequencing, and serotyping when the ability to perform these methods or the methods themselves are limited.
MATERIALS AND METHODS

Bacterial isolates.
A total of 227 Salmonella isolates (217 S. Typhi and 10 S. enterica serovar Paratyphi A) were used in this study (see Table S1 in the supplemental material). All bacterial isolates originated from previous investigations conducted in southern Vietnam between 1993 and 2005 or across seven other Asian countries between 2002 and 2004, as previously described (15) . Nineteen S. Typhi isolates that were previously wholegenome sequenced were used as controls for SNP typing and validation of the MLPA method; these isolates were provided by the Wellcome Trust Sanger Institute (United Kingdom) collection and are additionally described in Table S1 in the supplemental material (12) . The 10 S. Paratyphi A isolates originated from India and were included as an out-group for SNP genotyping and MLPA analysis.
Microbiological methods. All bacterial isolates were identified by standard biochemical tests and agglutination with Salmonella-specific antiserum (Murex Diagnostics, Dartford, United Kingdom). Antimicrobial susceptibilities were tested at the time of isolation by the modified BauerKirby disk diffusion method, as recommended by the CLSI guidelines (16) . The antimicrobial disks tested were chloramphenicol (CHL) (30 g), ampicillin (AMP) (10 g), trimethoprim-sulfamethoxazole (SXT) (1.25/23.75 g), ofloxacin (OFX) (5 g), ciprofloxacin (CIP) (5 g), and nalidixic acid (NAL) (30 g). MICs were determined by Etest against CIP, NAL, and OFX, according to the manufacturer's recommendations (AB Biodisk, Sweden). Mueller-Hinton agar and antimicrobial disks were purchased from UniPath, Basingstoke, United Kingdom. Escherichia coli strain ATCC 25922 and Staphylococcus aureus strain ATCC 25923 were used as control strains for these assays. The results were interpreted according to current CLSI guidelines (16) . An isolate was defined as multidrug resistant (MDR) if it was resistant to chloramphenicol, trimethoprim-sulfamethoxazole, and ampicillin.
PCR amplification and DNA sequencing. DNA was extracted from all S. Typhi isolates using the Wizard genomic DNA extraction kit (Promega, Fitchburg, WI). Oligonucleotide primers for the amplification of the quinolone resistance-determining regions (QRDRs) in the gyrA and parC genes in S. Typhi were as described in Table 1 . PCRs were performed under the following conditions: 92°C for 45 s, 55°C or 62°C (depending on the primer pair) for 45 s, and 74°C for 1 min, for 30 cycles, followed by a final extension step at 74°C for 2 min. DNA sequencing reactions were performed using the CEQ Dye Terminator cycle sequencing (DTCS) quick start kit (Beckman Coulter) and were sequenced using a CEQ 8000 capillary sequencer (Beckman Coulter). All resulting DNA sequences were analyzed using the CEQuence investigator CEQ2000XL (Beckman Coulter) before verification, alignment, and editing in BioEdit software (http://www.mbio.ncsu.edu/BioEdit/bioedit. html). BLASTn at the NCBI was used to compare all resulting gyrA and parC sequences to those of global S. Typhi isolates. PCR amplification was used to confirm the insertion or deletion of the target sequence across all S. Typhi isolates prior to probe design and MLPA analysis; the primers used are shown in Table 1 . PCRs were performed using the following conditions: 92°C for 45 s, 55 to 62°C for 45 s, and 74°C for 45 s, for 30 cycles, followed by a final extension step at 74°C for 2 min (Table 1) .
MLPA. All MLPA reagents were manufactured and supplied by MRCHolland (Amsterdam, The Netherlands). Sixteen S. Typhi-specific MLPA probes were designed according to the manufacturer's recommendations. The probes are described in Table 2 and target 11 S. Typhi indels (B, Q, A, K, E, F, S, C, H, N, and D) (Fig. 1) . MLPA was performed according to a standard protocol developed by MRC-Holland, as previously described (14) . Briefly, S. Typhi genomic DNA was diluted with Tris-EDTA (TE) buffer to final volume of 5 l (50 to 200 ng) and heated at 98°C for 10 min in a thermocycler (Bio-Rad). After denaturation, the DNA was hybridized with MLPA reagents at 60°C. After overnight incubation, ligation was performed at 54°C for 15 min, followed by 98°C for 5 min. Ten microliters of the ligation mixture was added to 30 l of PCR buffer. After equilibration at 60°C, 10 l of SALSA PCR master mix, containing the labeled forward primer 5=-FAM-GGGTTCCCTAAGGGTTGGA-3= (FAM, 6-carboxylfluorescein) and the unlabeled reverse primer 5=-GTGCCAGC AAGATCCAATCTAGA-3=, was added. PCR amplification was performed using 35 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 45 s, followed by 72°C for 20 min. The resulting MLPA amplicons were examined by agarose gel (3%) electrophoresis and by fragment analysis using an ABI 3130xl capillary electrophoresis system (Applied Biosystems). For fragment analysis, 0.5 l of PCR amplicon was mixed with 9.25 l of Hi-Di formamide and 0.25 l 500 LIZ size standard (GeneScan; Applied Biosystems). The mixture was incubated for 3 min at 95°C, chilled for 10 min, and analyzed. The resulting fragment analysis data were analyzed using GeneMapper v4.0 (Applied Biosystems). Data were analyzed using BioNumerics (Applied Maths, Belgium), and phylogenetic trees were drawn using Dendroscope v2.3. Single nucleotide polymorphism genotyping. A cross-sectional subset of 73 S. Typhi isolates was arbitrarily selected to encompass a range of locations, antimicrobial resistance patterns, studies in Vietnam, and dates of isolation for gold-standard SNP genotyping using the Illumina GoldenGate platform (see Table S1 in the supplemental material). DNA was extracted from all S. Typhi isolates as described above, and concentrations were assessed using the Quant-iT kit (Invitrogen, Carlsbad, CA) prior to SNP typing. The chromosomal haplotype of S. Typhi isolates was determined based on the SNPs present at 1,485 chromosomal loci identified previously from genome-wide surveys (12, 17) . All loci were interrogated using a GoldenGate (Illumina) custom assay according to the manufacturer's standard protocols, as described previously (10, 11, 18, 19) . SNP calls were generated from raw fluorescence signal data by clustering with a modified version of Illuminus, as described previously (10, 11, 18, 19) . SNP alleles were concatenated to generate a multiple-sequence alignment; maximum likelihood phylogenetic trees were fitted to each alignment using RAxML with a general time reversible plus gamma (GTRϩ␥) model and 1,000 bootstraps as previously described (11, 20) .
RESULTS
Development of MLPA to detect phylogenetically informative indels in the S. Typhi genome. Data gleaned from genome sequencing predicted that the presence or absence of certain indels within the S. Typhi chromosome might be phylogenetically informative markers for assigning S. Typhi isolates to the genotype groups originally defined by SNP analysis (12) . Consequently, conventional PCR assays were designed to independently detect 11 of these previously described indels (12) . Each target (A, B, C, D, E, F, H, K, N, Q, and S) was selected to represent one of the main branches of the S. Typhi phylogenetic tree, and where two indels were present on one branch, one was selected to avoid redundancy ( Table 1, Fig. 1 ). Conventional PCR amplification, detecting indels at the 11 target loci, was performed on DNA extracted from the 19 S. Typhi isolates that had been whole-genome sequenced (12) ( Table 3 ). The PCR amplification results (PCR ϩ /indel ϩ and PCR Ϫ /indel Ϫ )
corresponded precisely with the genome sequencing data, confirming the phylogenetic potential of these 11 indel targets in the selected isolates. An MLPA probe set was designed to detect the same 11 indels, as well as SNPs in the gyrA and parC genes and sequences within the conserved S. Typhi genes aroC, ssaV, and fliC to serve as controls for hybridization, amplification, and detection. The probe sequences and the predicted amplicon length for each target are shown in Table 2 . The gyrA and parC probes were designed to detect SNPs associated with reduced susceptibility to fluoroquinolones within the QRDRs. Although several mutations have been identified at gyrA codon 83, the most common mutation associated with fluoroquinolone resistance (TCC to TTC) (15, 21) changes serine to phenylalanine (S83F); thus, the gyrA probe was designed to target this mutation. Additionally, a spanning probe was added to differentiate mutations at codons 83 and 87 within gyrA; it was designed so that a wild-type allele would not yield a detectable DNA fragment and so other (non-S83F) mutations at codons 83 and 87 would generate a product of decreased intensity in comparison to any product yielded from the S83F mutation. The parC probe was designed to detect the most common fluoroquinolone resistance mutation (AGC to ATC), which changes serine to isoleucine at codon 80, and to yield a product only when an S. Typhi isolate contained the S80I mutation (15, 21) . The indel type was inferred by the absence of amplification or of peaks following fragment analysis (Fig. 2) .
Validation of MLPA for S. Typhi genotyping and detection of gyrA and parC mutations. MLPA was performed using DNA prepared from 19 global S. Typhi isolates that were previously wholegenome sequenced (Table 3 ) (12) . Analysis of the DNA fragments generated from these PCR amplifications demonstrated that all probes, including the controls, performed as anticipated, as they produced measurable and reproducible amplicons of the predicted sizes. Representative examples of the resulting DNA fragment analysis and gel electrophoresis are shown in Fig. 2 . Notably, the probes targeting the gyrA and parC mutations were able to distinguish between isolates with and without mutations in the QRDR. Figure 2 shows that the parC amplicon was detectable in isolates with a parC mutation, and a diminished gyrA signal was visible in isolates with a mutation at codons 83 and 87. The indel and QRDR patterns of the S. Typhi isolates yielded by MLPA corresponded precisely with the indel patterns and the gyrA and parC mutations anticipated from both the genome sequences and conventional PCR (Table 3) .
Next, 73 S. Typhi isolates of undetermined genotype from Bangladesh, China, India, Indonesia, Laos, Pakistan, and Vietnam and 10 S. Paratyphi A isolates from India (as a control) were typed by detecting SNP variations at 1,485 previously identified loci across the S. Typhi genome using a custom GoldenGate assay (see Table  S2 in the supplemental material). These data were used to determine a phylogenetic tree, which subdivided the 73 S. Typhi isolates into six main genotype groups, broadly corresponding to those previously defined as H1, H42, H50, H52, H58, and H59 ( Fig. 1 and 3) (3, 12) . Approximately three-quarters (54/73) of the genotyped S. Typhi isolates belonged to the H58 genotype, including isolates originating from Bangladesh, India, Laos, Pakistan, and Vietnam. As predicted, the 10 S. Paratyphi A isolates fell into the ancestral group of S. Typhi via SNP typing, i.e., were ancestral for all SNPs, as all mutations were S. Typhi specific (data not shown).
MLPA was then performed on the same 73 S. Typhi isolates (Fig. 3) . The H58 complex has a predicted indel pattern of KBCE and all 54 of the H58 (as determined by SNP typing) S. Typhi isolates produced this pattern (Fig. 3) . The MLPA indel patterns were also consistent with the SNP genotypes in all of the H1 (KB), H42 (KB), and H59 (KB) isolates (9/9 total). The five isolates belonging to H52 (predicted indel pattern KBCS) produced 3 KBC, 1 KBCS, and 1 KBCD MLPA pattern. The five H50 S. Typhi isolates (with a predicted KF indel pattern) produced four K patterns and one KS pattern. Thus, genotype predictions based on the detection of MLPA indel patterns matched those predicted from SNP-based genotype assignments in 66/73 (90.4%) of the S. Typhi isolates. The 10 S. Paratyphi A isolates produced amplicons for the aroC, fliC, and ssaV genes and produced peaks corresponding with an indel pattern of SF, which does not correlate with any predicted S. Typhi genotype (see Table S1 in the supplemental material).
MLPA of S. Typhi from eight Asian countries. Subsequently, MLPA typing was performed on an additional 144 S. Typhi isolates of undetermined genotype from Vietnam (88 isolates) and seven other Asian countries. The MLPA results were combined with data from the 73 S. Typhi isolates typed during validation (see Tables S1 and S2 in the supplemental material). According to antimicrobial susceptibility testing, 119/217 (54.8%) isolates were nalidixic acid resistant (NALR) and 82/217 (37.8%) isolates were MDR (Table 4) , and 71 isolates (32.7%) were both NALR and MDR (Fig. 4) . We also used the gyrA and parC MLPA amplicons to detect the presence of NALR-conferring mutations and compared these data to the antimicrobial susceptibility results (Table  4 , Fig. 4) .
We detected 10 different indel patterns in the 217 S. Typhi isolates (Fig. 4, Table 4 ). Fifty-nine percent of the isolates (128/ 217) produced a KBCE or KBCEN MLPA pattern, corresponding to the H58 genotype (Table 4 , Fig. 4 ). This H58 group included 90% of isolates from Vietnam (79/88), 79% of isolates from India (23/29), 53% of isolates from Bangladesh (9/17), 39% of isolates from Pakistan (7/18), 31% of isolates from Laos (6/21), and 29%
FIG 3
Comparison of MLPA and SNP genotyping for S. Typhi. The phylogenetic tree was determined by detecting SNP variations at 1,485 previously identified loci across the S. Typhi genomes of 73 isolates using a custom GoldenGate assay (see Table S1 in the supplemental material). The resulting tree was used to infer indel patterns (colored capitalized letters) and their associated branches. Examples of S. Typhi strains at pivotal locations throughout the tree are named, and the H58 group (KBCE indel pattern), consisting of 54 strains, is highlighted in blue.
of isolates from Nepal (4/14). We additionally identified 4 isolates with a KBCES indel pattern, and 41 isolates (18%) with a KB indel pattern (H42 haplotype) were identified and spanned all eight Asian countries. Twelve isolates (6%) produced a KBC (H52) indel pattern, and 22/217 (10%) isolates produced a K indel pattern. An additional three indel patterns (KE, KS, and KBCS) were identified across seven isolates, and two Chinese isolates produced amplicons for all loci and were deemed to be ancestral. Table S1 in the supplemental material). MLPA detected 106 isolates with an amplicon consistent with a mutation in gyrA and two isolates with a mutation in parC and a double mutation in gyrA; all were confirmed by sequencing (Fig.  4, Table 4 ). Of the 119 isolates with phenotypic NALR, 106 (90%) tested positive for a gyrA mutation by MLPA (Table 4) . The MLPA analysis revealed that the H58 indel patterns KBCE and KBCEN had an increased proportion of NALR isolates compared to other indel patterns (H58 NALR, non-H58 NALR) (P Ͻ 0.0001, Fisher's exact test; see Table 4 ). Furthermore, the same H58 indel group had an increased proportion of MDR strains compared to other indel patterns (H58 MDR versus non-H58 MDR) (P Ͻ 0.0001, Fisher's exact test).
DISCUSSION
Phylogenetically informative subgrouping is vital for understanding the local and regional strain circulations of bacterial pathogens. Diagnostic, research, and reference laboratories use a range of typing methods for recording and reporting bacterial diversity with a variety of pathogens (22, 23) . However, these methods often lack reproducibility, sensitivity, and phylogenetic relevance (24) . The consequence of these limitations is an inability to perform robust epidemiological investigations of circulating bacterial pathogens. Genomics offers a solution to these limitations, and DNA sequence-based methodologies can be used to improve bacterial subtyping (10, 25, 26) . However, whole-genome sequencing is currently too specialized and expensive to be employed in areas where typhoid is endemic. We aimed to address this and developed a simple and reproducible S. Typhi subtyping method that can be performed in locations with limited molecular biology equipment. The MLPA method utilizes a limited number of steps and can be conducted with a standardized set of reagents and protocols. The method we developed performs well and can be made commercially available, depending on the demand within the enteric fever research community. It is difficult to perform a direct cost comparison of MLPA and sequencing, as demand impacts the cost of the MLPA kit; however, we estimate a cost in the realm of $10 to $20 per isolate for MLPA compared to the current cost of $500 to $1,000 per isolate for next-generation sequencing (price estimated on 5ϫ to 15ϫ coverage of a whole S. Typhi genome, using a 454 Junior next-generation sequencer with current costs in Vietnam; this could be reduced by using commercial sequencing facilities).
The MLPA method successfully detected all 11 phylogenetically informative indels, permitting us to infer a genotype for each. In our test set of 73 S. Typhi isolates, MLPA indel patterns accurately predicted SNP-based genotype assignments in 90% of the strains. For the remaining isolates, the MLPA profiles were a combination of indels that were similar, but not identical, to those we anticipated from SNP genotypes. Our method also permitted the incorporation of probes targeting the QRDR regions of gyrA and parC. The ability to detect mutations in gyrA and parC is highly relevant for epidemiological studies of S. Typhi, as NALR S. Typhi has been reported in the majority of countries where typhoid is endemic (15, 19, 21, 27) . NALR is a reliable marker of isolates with a reduced susceptibility to fluoroquinolones, the most common group of antimicrobials used to treat typhoid. When treated with fluoroquinolones, NALR S. Typhi is associated with an extended fever clearance time, prolonged antimicrobial therapy, and an increased risk of treatment failure (28) . Therefore, knowing the prevalence of gyrA mutations in endemic locations is important for treatment and is of value to epidemiologists, clinicians, and those making guidelines for clinical care.
Among the 106 isolates in which NALR mutations were detected by MLPA, all gyrA and parC mutations were confirmed by direct PCR amplicon sequencing, indicating 100% specificity for the detection of mutations in these genes using MLPA. Notably, we detected only two strains containing the parC mutation; these strains were from India, confirming our previous observation that this mutation is rare and has only been identified in strains circulating in India (15) . There were 13 NALR isolates that tested negative for gyrA and parC mutations using MLPA; direct sequencing of the amplicons confirmed the MLPA data. We suggest that this 10% discrepancy between MLPA and NALR phenotypic data was caused by either fluctuation in zone size readings during antimicrobial susceptibility testing by disk diffusion or by novel mutations in the QRDR that were not represented in this assay (15) . The successful use of MLPA to identify point mutations is encouraging and suggests that this method can be adapted to establish a simple and robust alternative to SNP typing for S. Typhi and other monomorphic pathogens, which may be more phylogenetically informative than the use of genomic indels.
The potential limitations of our work include the lack of an incHI1 plasmid probe, a bias toward isolates from Vietnam, and the fact that some indel profiles are shared by several genetically diverse S. Typhi genotypes, while other indel profiles define much more homogeneous groups. Hence, the resolution offered by indel typing is somewhat varied. We suggest that the discrepancies between SNP and MLPA typing are induced by the stability of some indels in different lineages, predicting that some indel loci may not be as phylogenetically informative as others. However, notwithstanding these limitations, our comparison of genomewide SNP with MLPA typing showed that MLPA was able to distinguish between five common S. Typhi isolates and, most significantly, was able to correctly identify H58 strains from Vietnam and across Asia. Principally, we were able to distinguish H58 strains with and without gyrA mutations with 100% accuracy. It has been shown that H58 strains currently predominate in the majority of endemic locations, and there is an association between H58 strains and S83F gyrA mutations and an MDR phenotype (3, 13) . The MLPA data confirmed that H58 S. Typhi is dominant in Vietnam and is widely dispersed across Asia, and it is associated with both NALR and MDR in these regions. As the use of highresolution SNP typing and genome sequencing have previously reported similar associations, the ability of MLPA to reproduce this result confirms its reliability and potential utility for epidemiological investigations. We advocate a new system for the subtyping of S. Typhi and propose that indel detection, either by MLPA or conventional PCR, be adopted until SNP typing becomes more routine. We aim to develop a global Web-based S. Typhi, S. Paratyphi A, invasive nontyphoidal Salmonella reference network whereby serotyping is combined with simple genotyping information, antimicrobial resistance profiling, and the time and date of isolation. The use of a standardized kit-based assay, such as the one presented here, that can be adapted through targeted genome sequencing would allow for routine data sharing and a global resource for assessing international epidemiology and defining appropriate measures for therapy and vaccination.
In conclusion, we have developed a simple, reliable, and epidemiologically relevant method that can be used in laboratories with modest molecular biology equipment to subgroup S. Typhi and identify common NALR-associated mutations. This MLPA method can distinguish between strains that currently dominate the global population structure of S. Typhi, offering a more sensitive and simple alternative to other subgrouping methodologies that are currently being used in low-and middle-income countries.
